Duality Advisers, LP Eli Lilly & CO Transaction History

Duality Advisers, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $1.72 Million - $2.3 Million	-2,905 Reduced 26.96%	7,869 $6.12 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $1.18 Million - $1.39 Million	2,253 Added 26.44%	10,774 $6.28 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $3.7 Million - $5.11 Million	8,521 New	8,521 $4.58 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $485,268 - $569,777	-1,741 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $408,595 - $507,780	1,741 New	1,741 $499,000
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $3.71 Million - $4.6 Million	-16,496 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $3.66 Million - $4.5 Million	16,496 New	16,496 $3.81 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $8.41 Million - $10.9 Million	-46,594 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $7.66 Million - $9.91 Million	46,594 New	46,594 $8.71 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $1.19 Million - $1.57 Million	-9,110 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1.33 Million - $1.54 Million	9,110 New	9,110 $1.35 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $413,780 - $512,504	-3,870 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $11.8 Million - $12.8 Million	-110,380 Reduced 96.61%	3,870 $433,000
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $12.7 Million - $14.8 Million	114,250 New	114,250 $12.7 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.